Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy

Hui Chang; Liang Peng; Ya‐Lan Tao; Chen Chen; Wei‐Wei Xiao; Yong‐Hong Hu; Yuan‐Hong Gao

doi:10.1002/cam4.2179

Necessity of concurrent chemotherapy in N2‐3 nasopharyngeal carcinoma treated with neoadjuvant chemotherapy of ≥3 cycles followed by intensity‐modulated radiotherapy

Cancer Medicine ◽

10.1002/cam4.2179 ◽

2019 ◽

Vol 8 (6) ◽

pp. 2823-2831

Author(s):

Hui Chang ◽

Liang Peng ◽

Ya‐Lan Tao ◽

Chen Chen ◽

Wei‐Wei Xiao ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Neoadjuvant Chemotherapy ◽

Intensity Modulated Radiotherapy ◽

Concurrent Chemotherapy ◽

Intensity Modulated

Download Full-text

Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy

Scientific Reports ◽

10.1038/srep16664 ◽

2015 ◽

Vol 5 (1) ◽

Cited By ~ 16

Author(s):

Xiao-Jing Du ◽

Ling-Long Tang ◽

Lei Chen ◽

Yan-Ping Mao ◽

Rui Guo ◽

...

Keyword(s):

High Risk ◽

Nasopharyngeal Carcinoma ◽

Neoadjuvant Chemotherapy ◽

Locally Advanced ◽

Intensity Modulated Radiotherapy ◽

Concurrent Chemotherapy ◽

High Risk Patients ◽

Intensity Modulated ◽

Risk Patients

Download Full-text

Influence of concurrent chemotherapy on locoregionally advanced nasopharyngeal carcinoma treated with neoadjuvant chemotherapy plus intensity-modulated radiotherapy: A retrospective matched analysis

Scientific Reports ◽

10.1038/s41598-020-59470-w ◽

2020 ◽

Vol 10 (1) ◽

Cited By ~ 2

Author(s):

Fangzheng Wang ◽

Chuner Jiang ◽

Lai Wang ◽

Fengqin Yan ◽

Quanquan Sun ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Neoadjuvant Chemotherapy ◽

Intensity Modulated Radiotherapy ◽

Concurrent Chemotherapy ◽

Intensity Modulated

Download Full-text

The role of concurrent chemotherapy to intensity-modulated radiotherapy (IMRT) after neoadjuvant docetaxel and cisplatin treatment in locoregionally advanced nasopharyngeal carcinoma

Medical Oncology ◽

10.1007/s12032-015-0505-2 ◽

2015 ◽

Vol 32 (3) ◽

Cited By ~ 3

Author(s):

Lei Zhang ◽

Guo-ping Shan ◽

Pu Li ◽

Ping-jing Cheng

Keyword(s):

Nasopharyngeal Carcinoma ◽

Intensity Modulated Radiotherapy ◽

Concurrent Chemotherapy ◽

Intensity Modulated

Download Full-text

Experience of weekly cisplatin concurrent with intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma patients with resistance to neoadjuvant chemotherapy

Medicine ◽

10.1097/md.0000000000008434 ◽

2017 ◽

Vol 96 (44) ◽

pp. e8434 ◽

Cited By ~ 3

Author(s):

Chuanben Chen ◽

Taojun Chen ◽

Chaoxiong Huang ◽

Jing Wang ◽

Zhaodong Fei

Keyword(s):

Nasopharyngeal Carcinoma ◽

Neoadjuvant Chemotherapy ◽

Locally Advanced ◽

Intensity Modulated Radiotherapy ◽

Intensity Modulated ◽

Weekly Cisplatin

Download Full-text

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus neoadjuvant chemotherapy plus concurrent chemoradiotherapy for ascending or descending types of nasopharyngeal carcinoma: A retrospective study

American Journal of Otolaryngology ◽

10.1016/j.amjoto.2021.103193 ◽

2021 ◽

pp. 103193

Author(s):

Qin Lin ◽

Linbin Lu ◽

Xuewen Wang ◽

Yihong Lin ◽

Yaying Chen ◽

...

Keyword(s):

Retrospective Study ◽

Nasopharyngeal Carcinoma ◽

Neoadjuvant Chemotherapy ◽

Concurrent Chemoradiotherapy ◽

Intensity Modulated Radiotherapy ◽

Intensity Modulated

Download Full-text

Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy Does Not Improve Treatment Outcomes for Stage II Nasopharyngeal Carcinoma: A Phase 2 Multicenter Clinical Trial

Frontiers in Oncology ◽

10.3389/fonc.2020.01314 ◽

2020 ◽

Vol 10 ◽

Author(s):

Xiaodong Huang ◽

Xiaozhong Chen ◽

Chong Zhao ◽

Jingbo Wang ◽

Kai Wang ◽

...

Keyword(s):

Clinical Trial ◽

Nasopharyngeal Carcinoma ◽

Treatment Outcomes ◽

Intensity Modulated Radiotherapy ◽

Concurrent Chemotherapy ◽

Stage Ii ◽

Phase 2 ◽

Multicenter Clinical Trial ◽

Improve Treatment ◽

Intensity Modulated

Download Full-text

Ten-Year Results Of Intensity-Modulated Radiotherapy For T4 Nasopharyngeal Carcinoma: New Insight Into The Value Of Concurrent Chemotherapy

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.379 ◽

2020 ◽

Vol 108 (3) ◽

pp. e839

Author(s):

F.F. Kong ◽

R.P. Zhai ◽

J. Huang ◽

L.L. Ye ◽

R.W. Oei ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Intensity Modulated Radiotherapy ◽

Concurrent Chemotherapy ◽

Intensity Modulated ◽

Insight Into

Download Full-text

Survival without concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus intensity-modulated radiotherapy

Medicine ◽

10.1097/md.0000000000018484 ◽

2019 ◽

Vol 98 (51) ◽

pp. e18484 ◽

Cited By ~ 1

Author(s):

Wang Fangzheng ◽

Jiang Chuner ◽

Qin Haiyan ◽

Sun Quanquan ◽

Ye Zhimin ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Induction Chemotherapy ◽

Intensity Modulated Radiotherapy ◽

Concurrent Chemotherapy ◽

Intensity Modulated

Download Full-text

Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy

PLoS ONE ◽

10.1371/journal.pone.0161878 ◽

2016 ◽

Vol 11 (10) ◽

pp. e0161878 ◽

Cited By ~ 1

Author(s):

Ji-Jin Yao ◽

Guan-Qun Zhou ◽

Fan Zhang ◽

Wang-Jian Zhang ◽

Li Lin ◽

...

Keyword(s):

Nasopharyngeal Carcinoma ◽

Intensity Modulated Radiotherapy ◽

Concurrent Chemotherapy ◽

Intensity Modulated

Download Full-text

Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era

Radiotherapy and Oncology ◽

10.1016/j.radonc.2020.10.005 ◽

2021 ◽

Vol 155 ◽

pp. 56-64

Author(s):

Wei-Jie Luo ◽

Wen-Qing Zou ◽

Shao-Bo Liang ◽

Lei Chen ◽

Guan-Qun Zhou ◽

...

Keyword(s):

Risk Assessment ◽

Nasopharyngeal Carcinoma ◽

Tumor Response ◽

Intensity Modulated Radiotherapy ◽

Concurrent Chemotherapy ◽

Intensity Modulated ◽

Personalized Risk Assessment ◽

Personalized Risk

Download Full-text